| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Novocol Pharmaceutical of Canada, Inc. | 20260326 | 1 |
| These highlights do not include all the information needed to use CYKLX safely and effectively. See full prescribing information for CYKLX. CYKLX (articaine ophthalmic solution) 8%, for topical ophthalmic use Initial U.S. Approval: 2000 | American Genomics, LLC | 20251205 | 4 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine Hydrochloride 4% and Epinephrine 1:100,000 Injection (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Burkhart Dental Supply Co., Inc | Pierrel S.p.A. | 20241118 | 4 |
| These highlights do not include all the information needed to use SEPTOCAINE® safely and effectively. See full prescribing information for SEPTOCAINE®. SEPTOCAINE® (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Septodont Inc. | Novocol Pharmaceutical of Canada, Inc. | Septodont SAS Specialites Septodont | 20241023 | 14 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | NDC, Inc. | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 6 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Patterson Dental | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 6 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Patterson Dental | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 6 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | NDC, Inc. | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 6 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 1 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 1 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 1 |
| These highlights do not include all the information needed to use Zorcaine ® safely and effectively. See full prescribing information for Zorcaine ® . Zorcaine ® (articaine hydrochloride and epinephrine injection), intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Septodont, Inc. | Novocol Pharmaceutical of Canada, Inc. | 20240306 | 4 |
| These highlights do not include all the information needed to use ARTICADENT safely and effectively. See full prescribing information for ARTICADENT. Articadent ® (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Dentsply Pharmaceutical | Novocol Pharmaceutical of Canada, Inc. | 20240301 | 9 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Benco Dental | Novocol Pharmaceutical of Canada, Inc. | 20240301 | 7 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Novocol Pharmaceutical of Canada, Inc. | 20240301 | 1 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Novocol Pharmaceutical of Canada, Inc. | 20240301 | 1 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Benco Dental | Novocol Pharmaceutical of Canada, Inc. | 20240301 | 7 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (articaine hydrochloride and epinephrine injection), for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Henry Schein | Novocol Pharmaceutical of Canada, Inc. | 20240301 | 11 |
| These highlights do not include all the information needed to use Articaine HCl and Epinephrine safely and effectively. See full prescribing information for Articaine HCl and Epinephrine. Articaine HCl and Epinephrine Injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Safco Dental Supply Co. | PIERREL SPA | 20230114 | 7 |
| These highlights do not include all the information needed to use ORABLOC® safely and effectively. See full prescribing information for ORABLOC®. ORABLOC® (articaine HCl and epinephrine) injection, for intraoral submucosal infiltration use Initial U.S. Approval: 2000 | Pierrel S.p.A. | 20181122 | 20 |
| These highlights do not include all the information needed to use Ultacan® and Ultacan® forte safely and effectively. See full prescribing information for Ultacan® and Ultacan® forte. Ultacan® and Ultacan® forte (Articaine HCl 4% and epinephrine Injection, USP); Intraoral Submucosal Injection Articaine hydrochloride 4% and epinephrine 1:200,000 Articaine hydrochloride 4% and epinephrine 1:100,000 Initial U.S. Approval: 2000 | HANSAmed, Inc. | Sanofi-Aventis Deutschland GmbH | 20170720 | 1 |